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INTRODUCTION
Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disease marked by a decline in cognitive functions, primarily memory loss and language deficit which are often accompanied by behavioural and psychological symptoms such as depression, stress, anxiety and mood disturbances.
The pathophysiology of AD is complex and is characterized by neuronal degeneration (cholinergic neurons in particular), abnormal neurofibrillary tangles, toxic β-amyloid (Aβ) plaques and deficiencies of neurochemicals which are essential for neuronal transmission (Ros and Poirier, 2004) . Aβ cytotoxicity to neuronal cells has been identified as one of the major features in AD pathology, but the exact mechanisms of the cascade of events leading to neurotoxicity still remain unclear (Fukuyama et al., 1994; Fagarasan and Efthimiopoulos, 1996; Yan et al., 1997; Canevari et al., 2004) .
Some studies suggest that one pathway of Aβ induced cytotoxicity could be mediated by free radicals and oxidative stress (Hensley et al., 1994; Behl, 1994 Behl, , 1997 Opazo et al., 2000; Canevari et al., 2004) . Evidence obtained using cultured cells, such as sympathetic neurons (Greenlund et al., 1995) , has demonstrated that reactive oxygen species are produced during the early, but not the late phase of neuronal cell death, suggesting that their production serves as an early signal, rather than a toxic agent, to mediate apoptosis. It has also been demonstrated that Aβ increases concentrations of hydrogen peroxide (H 2 O 2 ) in cells (Behl et al., 1994) . Hydrogen peroxide is one of the F o r P e e r R e v i e w 4 typical inducers of apoptosis in neuronal cells (Whittemore et al., 1994; Satoh et al., 1996) .
Withania somnifera (L.) Dunal (Solanaceae) root (also known as 'ashwagandha' in Sanskrit and as 'Indian ginseng') is widely used in Ayurvedic medicine (Mishra et al., 2000; Houghton and Howes, 2005) as a nerve tonic and memory enhancer, with antiaging, anti-stress, immunomodulatory and antioxidant properties (Ziauddin et al., 1996; Archana and Namasivayan, 1999, Bhattacharya et al., 2001; Jayaprakasam et al., 2003) .
Some studies have investigated a pharmacological basis to explain the reputed effects of W. somnifera on cognition, and to assess the therapeutic potential for the steroidal derivatives from this species, particularly the withanolides. Studies in vitro and in vivo have investigated the potential of W. somnifera to modulate cholinergic function and extracts of the root, and withanolides isolated from this species (withaferin A, 2,3-dihydrowithaferin A and 5β,6β-epoxy-4β-hydroxy-1-oxowitha-2,14,24-trienolide), inhibit acetylcholinesterase (Schliebs et al., 1997; Choudhary et al. 2004 Choudhary et al. , 2005 Houghton et al. 2007; Vinutha et al. 2007 ).
Other studies show that extracts of W. somnifera root, and some of the withanolide derivatives in particular, promote dendrite formation in human neuroblastoma cells in vitro in a dose-dependent manner (Tohda et al., 2000; Zhao et al., 2002) ; withanolide A and withanosides IV and VI extend axons and dendrites, respectively, in vitro (Kuboyama et al., 2002) , and withanolide A is considered to reconstruct neuronal networks in vivo (Kuboyama et al., 2005) . In an animal model of dementia and spinal cord injury, withanolide A, withanoside IV, and withanoside VI restored presynapses and postsynapses (Tohda et al., 2000 (Tohda et al., , 2005 . Other studies have investigated various W.
somnifera extracts in vivo to explain the putative effects of W. somnifera, including 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Parihar and Hemnani, 2003; Sankar et al., 2007; Bhatnagar et al., 2009) . Root extracts from this species have also been shown to significantly reduce the number of hippocampal degenerating cells in the brains of stressed rodents (Jain et al., 2001 ) and were neuroprotective in animal models of Parkinson's disease (Ahmad et al., 2005; Sankar et al., 2007) and Huntington disease (Kumar and Kumar, 2009 ) . Although some in vivo studies using various animal models suggest W. somnifera extracts can improve antioxidant status and provide neuroprotection (Jain et al., 2001; Parihar and Hemnani, 2003; Sankar et al., 2007; Bhatnagar et al., 2009) Invitrogen (UK). Aβ and trypan blue were purchased from Sigma (UK).
Cells were maintained in RPMI media supplemented with 10 % heat-inactivated foetal bovine serum, 2 mM L-glutamine, 100 IU/ml penicillin-streptomycin in humidified 5 % CO 2 and 95 % air at 37 °C. All cells were cultured in culture flasks pre-coated with poly-D-lysine (0.1 mg/mL). Cells were differentiated for 2-3 days using 50 ng/mL NGF. Prior to experimental treatments, cells were microscopically examined to assess differentiation. Eighty percent or more of cells with neurite outgrowth extensions over 2-3-fold cell body size were considered to be differentiated PC12 cells (dPC12). The medium was changed every alternate day. Prior to confluence, cells were dislodged by mechanical scraping and split in 1:3 ratio. Before each experiment, cells were checked for viability using a trypan blue (0.5 %) dye exclusion method (Freshney, 2000) . Cells were counted using a haemocytometer and the density was adjusted to 1x10 5 cells/mL prior to plating in 96-well plates; cells in exponential growth phase were used. somnifera root extract (concentration range: 0.097 -50 µg/mL), prior to exposure to H 2 O 2 (concentration range: 12.5 µM -400 µM) from a freshly prepared 1000 µM stock solution. After 24 h the cell viability was determined by an MTT assay, as described below.
β-Amyloid (1-42) fibrils preparation. Aβ concentrations (0.007 -2 µg/mL) of aggregated Aβ peptide in a 96-well plate. Cell viability was then assessed by measuring cellular redox activity with the MTT assay described below.
MTT assay. PC12 cell viability was determined by the MTT reduction assay. In brief,
MTT, a tetrazolium salt, is cleaved to formazan by succinate dehydrogenase, an enzyme in the mitochondrial respiratory chain, by live cells. After pre-incubation of the dPC12 cells with the test extracts and toxicity inducers (H 2 O 2 or Aβ) for 24 h, cells were Liquid chromatography-serial mass spectrometry. The freeze dried aqueous extract of W. somnifera root was analysed by liquid chromatography-serial mass spectrometry (LC-MS n ) using an HPLC system (Thermo Scientific 'Surveyor' autosampler, pumps and diode array detector) coupled to a 3D ion-trap mass spectrometer (Thermo Scientific 'LCQ Classic') via an electrospray source. Chromatography was achieved on a 150 mm x 4.6 mm, 5 µm C18 column (Phenomenex 'Luna C18(2)') using a 1 ml/min mobile phase gradient of 10 % to 100 % aqueous acetonitrile containing 0.1 % formic acid over 40 min. The flow to the ESI source was reduced to 200 µl/min by a splitter and the source was operated using a needle voltage of ±4.2 kV and desolvation nitrogen gas flows of 80 (sheath) and 20 (auxillary) units. The heated capillary temperature was 220 ºC and standard tuning voltages (obtained from rutin) were used. The instrument was operated using Xcalibur 2.0 software and components in the LC-MS n analyses were detected using MassFrontier 4.0 (both Thermo Scientific). Withaferin A (LGC Standards, UK) was also subjected to LC-MS n analysis using this method.
Statistical analyses.
Results are expressed as the mean ± SEM. Student t-test was used to compare differences between test groups and the negative control (H 2 O 2 or Aβ only) using Graphpad statistical software; p<0.05 were considered significant. % cell viability was observed at extract concentrations from 6.11 µg/mL to 100 µg/mL, compared with the negative control (H 2 O 2 alone), with 50 and 100 µg/mL extract concentrations showing the greatest improvement compared with the negative control (p<0.001). At the highest extract concentration (200 µg/mL) the cytoprotective effects were abolished, due, perhaps, to direct cytotoxic and antiproliferative properties of W.
somnifera being expressed at high concentrations (Sabbaraju et al., 2006; Stan et al., 2008) . . A concentration-dependent decrease of cell survival was observed after exposure to Aβ over the concentration range of 0.007 to 2.0 µg/mL (Fig. 3) . The cell survival was expressed as a percentage of the control measured in the absence of Aβ peptide. The cell viability was decreased to approximately 50 % at 0.5 µg/mL and no further decrease was observed by increasing the Aβ concentration above 0.5 µg/mL.
Consequently, this concentration of Aβ was selected to induce cytotoxicity in further experiments to investigate the neuroprotective effect of W. somnifera extract against
Aβ-induced toxicity.
Effect of W. somnifera extract on viability of dPC12 cells against β-amyloid (1-42) -induced toxicity
The pre-treatment of W. somnifera extract (0.75 µg/mL -100 µg/mL) for 24 h prior to Aβ incubation produced dose-dependent attenuation of Aβ-induced toxicity in dPC12 cells. Maximum viability (80 % of positive control) was observed at the highest concentration (100 µg/mL) tested (Fig. 4) .
LC-MS n analysis
Positive ion LC-MS n analysis of the W. somnifera extract revealed numerous components (Fig. 5) . Component 36 was identified as withaferin A against a standard and together with two other isomeric withanolides (38 & 40), these constituted the main withanolide aglycones in the extract. The majority of the other components, eluting earlier in the analysis, were assigned as derivatives of withanolides (Table 1) . Among these were compounds clearly assignable as glycosides of withanolides (10, 21, 22, 25, More exact assignment of withanolides from W. somnifera was not determined due to the numerous isomeric forms of withanolides reported in the literature (CCD, 2010).
Other components were also assigned as withanolide derivatives. Following MS2 of the protonated molecule they generated a complex array of product ions, but among these suggesting that the compound contained a withanolide moiety. The major product ion was at m/z 649 and MS3 analysis of this ion produced a spectrum that was almost extracts will be more likely to represent the response when using differentiated, rather than with non-differentiated cells (Datki et al., 2003) . To induce Aβ peptide toxicity, the peptide fragment with a length of 1-42 amino acid residues was used, as this fragment aggregates very rapidly and is responsible for inducing toxicity as compared with nonaggregated peptides. The toxic effects of Aβ fragments have been well-documented in a number of studies (Behl et al., 1992; Michaelis et al., 1998; Limpeanchob et al., 2008) .
The present study demonstrated that pre-treatments of differentiated PC12 cells with an aqueous extract of W. somnifera root significantly protected dPC12 cells against both H 2 O 2 -and Aβ-induced cytotoxicity, in a concentration dependent manner. As Aβ is known to increase free radical production and lipid peroxidation in PC12 cells, leading to apoptosis and cell death (Jung et al., 2007) , the cytoprotective effects observed could be attributed to the presence of free radical scavenging compounds in the aqueous extract of W. somnifera. Evidence to support this mode of action has been shown previously. Inhibition of lipid peroxidation due to an antioxidant action has been observed both in vitro and in vivo with extracts of W. somnifera root and some of the component withanolides, including withaferin A (Dhuley, 1998; Panda et al., 1997; Bhattacharya et al., 2000; Chaurasia et al., 2000) , a compound detected in the W. somnifera extract investigated in the present study. In addition to the withanolides having antioxidant capacity and decreasing lipid peroxidation in rodent brains, withanolides also enhanced catalase and glutathione peroxidase activities in rat frontal cortex and striatum (Chaurasia et al., 2000; Mishra et al., 2000; Scartezzini and Speroni, 2000; Bhattacharya et al., 1997 and 2001; Subbaraju et al., 2006) . In another induced by oxidative stress mediated by free radicals in an animal model (Parihar et al., 2004) . W. somnifera root extract was also shown to significantly reduce the level of lipid peroxidation and improved the antioxidant status in an animal model of
Parkinson's disease (Sankar et al., 2007) . Other studies showed that W. somnifera root extract also imparted neuroprotective effects, observed in a 6-hydroxydopamineinduced model in rats, and a lithium-pilocarpine induced seizures model of status epilepticus in rats (Kulkarni et al., 1998) One in vitro study showed an interesting finding in which W. somnifera root extract significantly and dose-dependently increased the percentage of cells with neurites in human neuroblastoma SK-N-SH cells (Tohda et al., 2000) . However, one observation in our study was that at high concentrations (> 100 µg/mL), the aqueous extract exhibited cytotoxic and perhaps anti-proliferative properties against the dPC12 cell line, (Subbaraju et al., 2006; Stan et al., 2008) . Indeed, component 32, detected in the W. somnifera extract by LC-MS n analysis ( Table 1 , Fig. 5 ), showed mass spectral data consistent with the dimeric thiowithanolide, ashwagandhanolide, a compound reported to inhibit cell proliferation in various tumor cell lines (Subbaraju et al., 2006) .
In conclusion, this study demonstrated that an aqueous extract of W. somnifera root, in which numerous withanolide derivatives were detected, was neuroprotective against *p<0.05, **p<0.01 and ***p<0.001, compared with negative control. The protective effect of W. somnifera against Aβ induced cytotoxicity was evaluated after 24 hr incubation time. somnifera root aqueous extract. Peaks are assigned to withanolides, as presented in Table 1 ; compound 36 is assigned as withaferin A by comparison with a reference standard of withaferin A. the major ion species found in positive and negative modes (and the assignment of these ions), the deduced molecular mass (M r ) and the suggested molecular mass of the aglycone (A) determined from the positive and / or negative ion MS2 spectra.
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